( MENAFN - Straits Research) Introduction Cardiac ablation is a medical procedure for treating arrhythmias (irregular heartbeats). Arrhythmias are electrical irregularities in the heart that can cause it to beat too fast (tachycardia), too slowly (bradycardia), or irregularly. Cardiac ablation is commonly recommended when medicines and other therapies fail to control or eliminate these abnormal heart rhythms.
A growing senior population, combined with an increasing population base of cardiovascular disease patients, technological advancements in the field of ablation devices, and growing awareness about the advantages of cardiac ablation procedures over conventional therapeutic and surgical procedures, all contribute to the global cardiac ablation market share . Significant cost-cutting initiatives conducted by various governments and ongoing healthcare reforms in the United States are, however, some of the primary factors hindering market growth. Market DynamicsIncreasing Prevalence of Cardiac Arrhythmias Drives the Global Market The prevalence of cardiac arrhythmias such as atrial fibrillation, atrial flutter, and ventricular tachycardia has raised cardiac ablation demand.
Arrhythmias increase as the population ages, and lifestyle factors cause cardiac illness. WHO: Cardiovascular diseases, especially arrhythmias, are the leading cause of death globally. The most common arrhythmia, atrial fibrillation (AF), is being discovered in more people.
The American Heart Association .
